The Study
Investigating the Aβ and tau pathology in autosomal dominant Alzheimer’s disease: insights from hybrid PET/MRI and network mapping
This study looked at people with a rare inherited form of Alzheimer’s and saw that when they had more of a sticky protein called tau in their brain, their brain networks acted differently. But it didn’t change anything or wait to see what happens next — so we can’t say one thing causes the other, just that they show up together.
Analysis score
Maximum 44 for a cross-sectional study.
Where the score came from
Scientists studied people who will definitely get Alzheimer’s because of their genes, but who don’t have symptoms yet. They looked at brain scans to see how two bad proteins — amyloid and tau — build up over time.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 544 / 100
Quality score
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Key takeaways
Summary
Based on the study abstract and findings.
- 1These brain changes happen long before memory problems appear, meaning we might be able to detect and treat Alzheimer’s much earlier.
- 2Amyloid builds up 20 years before symptoms, especially in the striatum; tau only shows up in some people close to when symptoms will start.
- 3When tau is present, brain networks change — some areas become more connected, others less.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Alzheimer's Research & Therapy
Year
2025
Authors
Zhi Zhou, Qigeng Wang, Linwen Liu, Qi Wang, Xiaojun Zhang, Can Li, Jiajin Liu, Yidan Wei, Jin Gao, Liping Fu, Ruimin Wang
Related Content
Claims (6)
Amyloid-beta builds up in the brain about 20 years before a person shows signs of Alzheimer's disease.
In people with a genetic form of Alzheimer’s disease who show no symptoms, amyloid-beta builds up in specific brain regions before tau pathology appears, and tau accumulation becomes more severe as they approach the expected age of symptom onset.
A new imaging method that combines tau-PET and resting-state fMRI scans detects consistent changes in brain network connections linked to tau protein buildup in people who carry Alzheimer’s disease risk but show no symptoms.
In people genetically predisposed to Alzheimer’s disease who show early tau protein buildup but no symptoms, specific brain networks show stronger connections in some regions and weaker connections in others, reflecting structural changes before memory problems appear.
In people genetically predisposed to Alzheimer’s disease but without symptoms, amyloid-beta accumulates more in the striatum than in the cortex in some individuals, and this accumulation is linked to the presence of tau protein pathology.
In people who carry a genetic form of Alzheimer’s but show no symptoms, tau protein buildup is not higher than in people without the gene, except in those who are closer to developing symptoms, meaning tau accumulation happens near the end of the silent phase before symptoms appear.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.